July 27, 2017 9:59 PM ET

Biotechnology

Company Overview of ArQule, Inc.

Executive Profile

Timothy C. Barabe M.B.A.

Independent Director, ArQule, Inc.
AgeTotal Calculated CompensationThis person is connected to 5 Board Members in 5 different organizations across 10 different industries.

See Board Relationships
64$76,728

Background

Mr. Timothy C. Barabe, also known as Tim, M.B.A., served as the Chief Financial Officer and Executive Vice President and at Affymetrix Inc. from March 15, 2010 to June 28, 2013 and also served as its Principal Accounting Officer until June 28, 2013. Mr. Barabe served led Affymetrix's financial functions as well as the treasury, investor relations and information technology departments. He served as the Chief Financial Officer and Principal Accounting Officer of Human ...

Corporate Headquarters

One Wall Street
Burlington, Massachusetts 01803

United States

Phone: 781-994-0300
Fax: --

Board Members Memberships

2001-Present
Independent Director
2014-Present
Independent Director
2015-Present
Director
2015-Present
Director
2016-Present
Director

Education

MBA
Loyola University Chicago
BBA
University Of Massachusetts

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

Total Annual Cash Compensation$60,250
Total Calculated Compensation$76,728
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Adam R. Craig M.D., Ph.D., M.B.A.President, CEO & Director
CTI BioPharma Corp.
--
Ali Fattaey Ph.D.Chief Executive Officer, President and Director
Curis, Inc.
$527.7K
Raul R. Rodriguez Chief Executive Officer, President and Director
Rigel Pharmaceuticals, Inc.
$618.0K
Adelene Q. Perkins Chairman and Chief Executive Officer
Infinity Pharmaceuticals, Inc.
$668.8K
Michael P. Bailey President, CEO & Director
AVEO Pharmaceuticals, Inc.
$444.1K
Compensation as of Fiscal Year --.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact ArQule, Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.